Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
Apotheek MOENS-MAMPAEY from Niel, company number BE0832692243, closed financial year 2025 with a result of € 7,763 after tax. For that financial year Apotheek MOENS-MAMPAEY recorded a gross margin of € 99,311 and equity of € 207,383. Compared with financial year 2024, the result moved from € 3,794 to € 7,763. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 207,383
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 7,763
▲ 105% vs 2024
Profit after tax over the fiscal year.
€ 30,056
▲ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 194,983.
People and assets in 2025
0.8
Average over the fiscal year, from the social balance sheet.
€ 56,349
▲ 1% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 87
▼ 71% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 5,000
Loans from banks and other lenders, long and short.
€ 246,696
▲ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 18,320
▲ 30% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 90,207 | € 107,317 | € 86,248 | € 99,311 | ▲ 15% |
| Profit after taxes | € 1,720 | € 36,226 | € 3,794 | € 7,763 | ▲ 105% |
| Equity | € 159,601 | € 195,827 | € 199,620 | € 207,383 | ▲ 4% |
| Total debts | € 313,574 | € 211,076 | € 314,637 | € 377,305 | ▲ 20% |
| Cash | € 43,180 | € 32,742 | € 29,763 | € 30,056 | ▲ 1% |
| Land & buildings | € 5,888 | € 5,271 | € 4,653 | € 4,035 | ▼ 13% |
| Retained profit | € 147,201 | € 183,427 | € 187,220 | € 194,983 | ▲ 4% |
| Dividend | € 100,000 | € 0 | € 0 | € 0 | |
| Bank debt | € 0 | € 0 | € 5,000 | € 5,000 | |
| Balance sheet total | € 473,175 | € 406,903 | € 514,257 | € 584,688 | ▲ 14% |
| Employees (FTE) | 0.9 | 0.6 | 0.8 | 0.8 |
Key figures of Apotheek MOENS-MAMPAEY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek MOENS-MAMPAEY?
What happened at Apotheek MOENS-MAMPAEY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 7,763 (▲ 105% vs 2024). Source: NBB ↗
- Fimovar NV became a director. NBB
- New establishment in Niel. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,720 profit in 2022 to € 7,763 profit in 2025.
Paid € 8,468 in corporate taxes since 2022.
Best year ever: 2023, with € 36,226 profit.
Paid out € 100,000 in dividends to the owners in total.
A new publication or filing at Apotheek MOENS-MAMPAEY? We notify you, reason included.
Follow Apotheek MOENS-MAMPAEYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of FIMOVAR comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek MOENS-MAMPAEYBehind Apotheek MOENS-MAMPAEY is Fimovar NV. The shares are held by FIMOVAR (100%).
Directors
According to the 2025 annual accounts
Bestuurder · represented by Filip Moens
Also active at: APOTHEEK MOENS MORTSEL, APOTHEEK MOENS NIEL
since 2020
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Emiel Dewittstraat 1
2845 Niel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0832.692.243
- VAT number
- BE 0832.692.243
- Registered office
- Emiel Dewittstraat 1, 2845 Niel
- Names & denominations
- Apotheek MOENS-MAMPAEY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2011
- Peppol
- Active · Active since 15 Apr 2025
- Activities · NACE
Detailhandel in farmaceutische producten